Updates in chimeric antigen receptor T-cell therapy for lymphoma / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
;
(12): 3-4, 2017.
Article
in Chinese
| WPRIM
| ID: wpr-507208
ABSTRACT
Tremendous success has emerged in chimeric antigen receptor (CAR)-T cell therapy over the past few years, especially in leukemia and lymphoma. The first CAR-T cell product might be available in America in 2017 due to the emergence of the critical results. This paper focused on the key data presented at the 58th American Society of Hematology Annual Meeting.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Journal of Leukemia & Lymphoma
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS